| Dr Ronald Mark Berger, OD | |
|
5012 Dorsey Hall Dr, Suite 105, Ellicott City, MD 21042-7711 | |
| (410) 730-8878 | |
| (410) 997-8272 |
| Full Name | Dr Ronald Mark Berger |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 49 Years |
| Location | 5012 Dorsey Hall Dr, Ellicott City, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063448983 | NPI | - | NPPES |
| 269818800 | Medicaid | MD |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Center For Vision Development, Llc | 7214075084 | 3 |
News Archive
What does uncovering the true authorship of plays attributed to Shakespeare have to do with identifying our genetic ancestors or classifying new life forms?
RemedyMD has identified the need within the HSCT community to build software that can aggregate, link, harmonize, and analyze data from patients and donors and then report data as necessary to the CIBMTR.
Life expectancy in the USA is no longer rising. This stagnation has long been largely attributed to increasing numbers of drug deaths due to the opioid crisis.
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, reported financial results for the quarter and six months ended June 30, 2010, and presented an update on recent clinical and corporate progress.
OXIS INTERNATIONAL, INC. (Pink Sheets: OXIS, Paris: OXI) announced today that Ergoplex™, its commercial anti-inflammatory product using its patented compound, Ergothioneine, a powerful antioxidant, has shown very good acceptance in a recent direct mail test.
› Verified 1 days ago
| Provider Name | The Center For Vision Development, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1629201991 PECOS PAC ID: 7214075084 Enrollment ID: O20091116000379 |
News Archive
What does uncovering the true authorship of plays attributed to Shakespeare have to do with identifying our genetic ancestors or classifying new life forms?
RemedyMD has identified the need within the HSCT community to build software that can aggregate, link, harmonize, and analyze data from patients and donors and then report data as necessary to the CIBMTR.
Life expectancy in the USA is no longer rising. This stagnation has long been largely attributed to increasing numbers of drug deaths due to the opioid crisis.
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, reported financial results for the quarter and six months ended June 30, 2010, and presented an update on recent clinical and corporate progress.
OXIS INTERNATIONAL, INC. (Pink Sheets: OXIS, Paris: OXI) announced today that Ergoplex™, its commercial anti-inflammatory product using its patented compound, Ergothioneine, a powerful antioxidant, has shown very good acceptance in a recent direct mail test.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ronald Mark Berger, OD 5012 Dorsey Hall Dr, Suite 105, Ellicott City, MD 21042-7711 Ph: (410) 730-8878 | Dr Ronald Mark Berger, OD 5012 Dorsey Hall Dr, Suite 105, Ellicott City, MD 21042-7711 Ph: (410) 730-8878 |
News Archive
What does uncovering the true authorship of plays attributed to Shakespeare have to do with identifying our genetic ancestors or classifying new life forms?
RemedyMD has identified the need within the HSCT community to build software that can aggregate, link, harmonize, and analyze data from patients and donors and then report data as necessary to the CIBMTR.
Life expectancy in the USA is no longer rising. This stagnation has long been largely attributed to increasing numbers of drug deaths due to the opioid crisis.
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, reported financial results for the quarter and six months ended June 30, 2010, and presented an update on recent clinical and corporate progress.
OXIS INTERNATIONAL, INC. (Pink Sheets: OXIS, Paris: OXI) announced today that Ergoplex™, its commercial anti-inflammatory product using its patented compound, Ergothioneine, a powerful antioxidant, has shown very good acceptance in a recent direct mail test.
› Verified 1 days ago
Dr. Dana Taylor, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5012 Dorsey Hall Dr, Suite 105, Ellicott City, MD 21042 Phone: 410-730-8878 Fax: 410-997-8272 | |
Dr. Christina E. Generie, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5725 Richards Valley Rd Ste A9, A-9, Ellicott City, MD 21043 Phone: 443-420-8113 Fax: 443-420-8113 | |
Revolutioneyes Optometrist Medicare: Medicare Enrolled Practice Location: 5725 Richards Valley Rd Ste A9, Ellicott City, MD 21043 Phone: 443-420-8113 Fax: 443-420-8113 | |
Dr. Joshua S Gordon, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 9051 Baltimore National Pike, Ellicott City, MD 21042 Phone: 410-465-4080 Fax: 410-461-8650 | |
Ellicott City Total Eye Care Llc Optometrist Medicare: Medicare Enrolled Practice Location: 5012 Dorsey Hall Dr, Suite 105, Ellicott City, MD 21042 Phone: 410-730-8878 Fax: 410-997-8272 | |
Leslie Toll, OD Optometrist Medicare: Medicare Enrolled Practice Location: 10050 Baltimore National Pike, Suite F100, Ellicott City, MD 21042 Phone: 410-461-2020 Fax: 410-461-2672 |